Anna Thora Grimsrud1, Morna Cornell, Matthias Egger, Andrew Boulle, Landon Myer. 1. Centre for Infectious Disease Epidemiology & Research, School of Public Health & Family Medicine, University of Cape Town, Falmouth Building, Anzio Road, Observatory, Cape Town, 7925 South Africa. agrimsrud@gmail.com
Abstract
OBJECTIVE: To examine the impact of different definitions of loss to follow-up (LTFU) on estimates of program outcomes in cohort studies of patients on antiretroviral therapy (ART). STUDY DESIGN AND SETTING: We examined the impact of different definitions of LTFU using data from the International Epidemiological Databases to Evaluate AIDS-Southern Africa. The reference approach, Definition A, was compared with five alternative scenarios that differed in eligibility for analysis and the date assigned to the LTFU outcome. Kaplan-Meier estimates of LTFU were calculated up to 2 years after starting ART. RESULTS: Estimated cumulative LTFU were 14% and 22% at 12 and 24 months, respectively, using the reference approach. Differences in the proportion LTFU were reported in the alternative scenarios with 12-month estimates of LTFU varying by up to 39% compared with Definition A. Differences were largest when the date assigned to the LTFU outcome was 6 months after the date of last contact and when the site-specific definition of LTFU was used. CONCLUSION: Variation in the definitions of LTFU within cohort analyses can have an appreciable impact on estimated proportions of LTFU over 2 years of follow-up. Use of a standardized definition of LTFU is needed to accurately measure program effectiveness and comparability between programs.
OBJECTIVE: To examine the impact of different definitions of loss to follow-up (LTFU) on estimates of program outcomes in cohort studies of patients on antiretroviral therapy (ART). STUDY DESIGN AND SETTING: We examined the impact of different definitions of LTFU using data from the International Epidemiological Databases to Evaluate AIDS-Southern Africa. The reference approach, Definition A, was compared with five alternative scenarios that differed in eligibility for analysis and the date assigned to the LTFU outcome. Kaplan-Meier estimates of LTFU were calculated up to 2 years after starting ART. RESULTS: Estimated cumulative LTFU were 14% and 22% at 12 and 24 months, respectively, using the reference approach. Differences in the proportion LTFU were reported in the alternative scenarios with 12-month estimates of LTFU varying by up to 39% compared with Definition A. Differences were largest when the date assigned to the LTFU outcome was 6 months after the date of last contact and when the site-specific definition of LTFU was used. CONCLUSION: Variation in the definitions of LTFU within cohort analyses can have an appreciable impact on estimated proportions of LTFU over 2 years of follow-up. Use of a standardized definition of LTFU is needed to accurately measure program effectiveness and comparability between programs.
Authors: Matthias Egger; Didier K Ekouevi; Carolyn Williams; Rita Elias Lyamuya; Henri Mukumbi; Paula Braitstein; Tyler Hartwell; Claire Graber; Benjamin H Chi; Andrew Boulle; François Dabis; Kara Wools-Kaloustian Journal: Int J Epidemiol Date: 2011-05-18 Impact factor: 7.196
Authors: Morna Cornell; Anna Grimsrud; Lara Fairall; Matthew P Fox; Gilles van Cutsem; Janet Giddy; Robin Wood; Hans Prozesky; Lerato Mohapi; Claire Graber; Matthias Egger; Andrew Boulle; Landon Myer Journal: AIDS Date: 2010-09-10 Impact factor: 4.177
Authors: Kate Clouse; Audrey Pettifor; Mhairi Maskew; Jean Bassett; Annelies Van Rie; Cynthia Gay; Frieda Behets; Ian Sanne; Matthew P Fox Journal: AIDS Date: 2013-02-20 Impact factor: 4.177
Authors: Benjamin H Chi; Constantin T Yiannoutsos; Andrew O Westfall; Jamie E Newman; Jialun Zhou; Carina Cesar; Martin W G Brinkhof; Albert Mwango; Eric Balestre; Gabriela Carriquiry; Thira Sirisanthana; Henri Mukumbi; Jeffrey N Martin; Anna Grimsrud; Melanie Bacon; Rodolphe Thiebaut Journal: PLoS Med Date: 2011-10-25 Impact factor: 11.069
Authors: Franziska Schöni-Affolter; Olivia Keiser; Albert Mwango; Jeffrey Stringer; Bruno Ledergerber; Lloyd Mulenga; Heiner C Bucher; Andrew O Westfall; Alexandra Calmy; Andrew Boulle; Namwinga Chintu; Matthias Egger; Benjamin H Chi Journal: PLoS One Date: 2011-12-19 Impact factor: 3.240
Authors: Morna Cornell; Leigh F Johnson; Michael Schomaker; Frank Tanser; Mhairi Maskew; Robin Wood; Hans Prozesky; Janet Giddy; Kathryn Stinson; Matthias Egger; Andrew Boulle; Landon Myer Journal: Lancet HIV Date: 2015-08-04 Impact factor: 12.767
Authors: Meridith Blevins; Eurico José; Fernandes R Bilhete; Lara M E Vaz; Bryan E Shepherd; Carolyn M Audet; Sten H Vermund; Troy D Moon Journal: AIDS Res Hum Retroviruses Date: 2014-12-17 Impact factor: 2.205
Authors: Nicole L De La Mata; Penh S Ly; Kinh V Nguyen; Tuti P Merati; Thuy T Pham; Man P Lee; Jun Y Choi; Jeremy Ross; Matthew G Law; Oon T Ng Journal: J Acquir Immune Defic Syndr Date: 2017-04-15 Impact factor: 3.731
Authors: Anthony Obeid; Xinxiao Gao; Ferhina S Ali; Christopher M Aderman; Abtin Shahlaee; Murtaza K Adam; Sundeep K Kasi; Leslie Hyman; Allen C Ho; Jason Hsu Journal: JAMA Ophthalmol Date: 2018-11-01 Impact factor: 7.389
Authors: Anna Grimsrud; Morna Cornell; Michael Schomaker; Matthew P Fox; Catherine Orrell; Hans Prozesky; Kathryn Stinson; Frank Tanser; Matthias Egger; Landon Myer Journal: J Epidemiol Community Health Date: 2015-12-23 Impact factor: 3.710